封面
市場調查報告書
商品編碼
1741473

高階CELLOMICS市場:按產品類型、按應用、按技術、按最終用戶、按地區

High End Cellomics Market, By Product Type, By Application, By Technology, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

高階CELLOMICS市場規模預計在 2025 年達到 46.4 億美元,預計到 2032 年將達到 85.4 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 9.1%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 46.4億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 9.10% 2032年價值預測 85.4億美元

高階CELLOMICS市場正經歷強勁成長,並已成為細胞分析和研究領域的焦點。高階CELLOMICS是指用於在分子層面上研究細胞的先進技術和儀器。這些技術使科學家和研究人員能夠分析細胞的結構、功能和動態,從而推動藥物研發、疾病診斷和個人化醫療等各個領域取得重要進展。

隨著基於細胞的研究需求日益成長,以及對細胞過程進行精準分析的需求日益成長,高階CELLOMICS日益受到關注。高解析度顯微鏡和高內涵篩檢等成像技術的進步,為高階CELLOMICS市場的成長做出了巨大貢獻。此外,人工智慧和機器學習演算法的融合,徹底改變了複雜細胞數據的分析和解讀方式。

市場動態:

高階CELLOMICS市場受到多種因素驅動,包括對個人化醫療日益成長的需求以及對藥物研發和市場開發的日益關注。癌症和心血管疾病等慢性疾病的發生率不斷上升,進一步推動了對先進細胞分析技術的需求。此外,製藥和生技公司對研發活動的投入也為市場發展做出了重大貢獻。

例如,2023年10月26日,研究和科技公司A4cell宣布一項310萬美元的重大投資。這項重大投資將成為徹底改變活體單細胞分析領域的催化劑。這項投資將主要用於加強研發力度,引進高技能的科學家和工程師,並加速開發旨在揭示活體單細胞奧秘的最尖端科技。

然而,高階CELLOMICS市場也面臨一些挑戰。採購和維護先進細胞分析設備的高成本阻礙了市場發展,尤其是在新興市場。此外,缺乏能夠處理和分析複雜細胞數據的專家,也阻礙了高階CELLOMICS技術的廣泛應用。

儘管面臨諸多挑戰,高階CELLOMICS市場仍蘊藏著許多成長機會。單細胞定序和空間轉錄組學等新型細胞分析技術的出現,為進一步探索和理解細胞機制鋪平了道路。此外,多體學資料分析的整合以及創新成像模式的開發,也為市場拓展提供了廣闊的機會。

本研究的主要特點

  • 本報告對全球高階CELLOMICS市場進行了詳細分析,包括其市場規模和預測期為 2025 年至 2032 年的複合年成長率(以 2024 年為基準年)。
  • 它揭示了不同細分市場中的潛在收益成長機會,並為高階CELLOMICS市場提供了一系列有吸引力的投資提案。
  • 它提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及高階CELLOMICS市場主要企業採用的競爭策略的主要考察。
  • 本報告介紹了全球高階CELLOMICS市場的主要企業,包括其公司背景、產品系列、主要成就、財務表現和策略。
  • 參與的主要公司包括賽默飛世爾科技、丹納赫、珀金埃爾默、BD、Bio-Rad Laboratories、安捷倫主要企業、Illumina、Luminex、默克集團、通用電氣醫療集團、布魯克、NanoString Technologies、10x Genomics、Fluidigm、Celsi、Berkeley Flus、Genpnaics Flus、美天掟ics、BioOronl、Hornaics、Yetc​​k照
  • 報告中的見解將使負責人和經營團隊能夠就產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 本報告針對高階CELLOMICS市場的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員將受益於用於分析全球高階CELLOMICS市場的策略矩陣,從而更容易做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 個人化醫療需求日益成長
  • 採購和維護先進細胞分析設備的高成本
  • 單細胞定序與空間轉錄組學等新細胞分析技術的出現
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 全球高階CELLOMICS市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球高階CELLOMICS市場(依產品類型)

  • 裝置
  • 試劑和耗材
  • 軟體
  • 服務

6. 全球高階CELLOMICS市場(按應用),2020 年至 2032 年

  • 藥物研發
  • 癌症研究
  • 神經科學
  • 幹細胞研究與再生醫學
  • 個人化醫療
  • 其他

7. 2020 年至 2032 年全球高階CELLOMICS市場(按技術分類)

  • 顯微鏡
  • 流式細胞技術
  • 單細胞基因體學
  • 質譜法
  • 次世代定序
  • 其他

8. 2020 年至 2032 年全球高階CELLOMICS市場(依最終使用者分類)

  • 生物技術和製藥公司
  • 醫院和診斷實驗室
  • 受託研究機構
  • 其他

9. 全球高階CELLOMICS市場(按地區),2020 年至 2032 年

  • 北美洲
      • 美國
      • 加拿大
  • 歐洲
      • 英國
      • 德國
      • 義大利
      • 法國
      • 西班牙
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 日本
      • 印度
      • ASEAN
      • 澳洲
      • 韓國
      • 其他亞太地區
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中東
      • GCC
      • 以色列
      • 其他中東地區
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第10章 競爭格局

  • Thermo Fisher Scientific
  • Danaher
  • PerkinElmer
  • BD
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Illumina
  • Luminex
  • Merck KGaA
  • GE Healthcare
  • Bruker
  • Nanostring Technologies
  • 10x Genomics
  • Fluidigm
  • Celsee
  • Berkeley Lights
  • Miltenyi Biotec
  • Bionano Genomics
  • Bio-Techne
  • Sphere Fluidics

第 11 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6303

High End Cellomics Market is estimated to be valued at USD 4.64 Bn in 2025 and is expected to reach USD 8.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.64 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.10% 2032 Value Projection: USD 8.54 Bn

The high end cellomics market is experiencing significant growth and has become a key focus area in the field of cellular analysis and research. High end cellomics refers to the advanced technologies and instruments used for the study of cells at a molecular level. These technologies enable scientists and researchers to analyze cell structure, function, and dynamics, leading to important advancements in various fields such as drug discovery, disease diagnosis, and personalized medicine.

High end cellomics has gained prominence due to the increasing demand for cell-based research and the need for precise and accurate analysis of cellular processes. Advancements in imaging technologies, such as high-resolution microscopy and high-content screening, have greatly contributed to the growth of the high end cellomics market. Additionally, the integration of artificial intelligence and machine learning algorithms have revolutionized the analysis and interpretation of complex cellular data.

Market Dynamics:

The high end cellomics market is driven by several factors including the increasing demand for personalized medicine and the growing focus on drug discovery and development. The rising prevalence of chronic diseases, such as cancer and cardiovascular disorders, further fuels the demand for advanced cell analysis technologies. Additionally, investments in research and development activities by pharmaceutical and biotechnology companies have significantly contributed to the market growth.

For instance, on October 26, 2023, A4cell, a research and technology company, announced a significant US$ 3.1 million investment. This significant investment will act as a catalyst to completely transform the field of live single-cell analysis. The investment will mainly go towards stepping up R&D efforts, growing their highly skilled staff of scientists and engineers, and quickening the development of cutting-edge technologies intended to reveal the mysteries concealed in live single cells.

However, the high end cellomics market also faces certain challenges. The high costs associated with the procurement and maintenance of advanced cell analysis instruments poses a barrier to market growth, especially in developing regions. Moreover, the lack of skilled professionals proficient in handling and analyzing complex cellular data hampers the widespread adoption of high end cellomics technologies.

Despite these challenges, the high end cellomics market presents numerous opportunities for growth. The emergence of new cellular analysis techniques, such as single-cell sequencing and spatial transcriptomics, opens avenues for further exploration and understanding of cellular mechanisms. Additionally, the integration of multi-omics data analysis and the development of innovative imaging modalities offer promising opportunities for market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global high end cellomics market including its market size (in US$ Bn) and compound annual growth rate (CAGR %) over the forecast period of 2025-2032, with 2024 as the base year
  • It elucidates potential revenue growth opportunities across different market segments and provides attractive investment proposition matrices for the high end cellomics market
  • The study offers key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players in the high end cellomics market
  • It profiles key players in the global high end cellomics market, highlighting their company backgrounds, product portfolios, key achievements, financial performance, and strategies
  • The report includes a comprehensive list of key companies covered in the study including Thermo Fisher Scientific, Danaher, PerkinElmer, BD, Bio-Rad Laboratories, Agilent Technologies, Illumina, Luminex, Merck KGaA, GE Healthcare, Bruker, Nanostring Technologies, 10x Genomics, Fluidigm, Celsee, Berkeley Lights, Miltenyi Biotec, Bionano Genomics, Bio-Techne, and Sphere Fluidics
  • Insights from this report will enable marketers and management authorities to make informed decisions regarding product launches, upgrades, market expansion, and marketing strategies
  • The report caters to various stakeholders in the high end cellomics market including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders will benefit from the strategy matrices used in the analysis of the global high end cellomics market, facilitating ease in decision-making

High End Cellomics Market Segmentation:

  • By Product Type
    • Instruments
    • Reagents and Consumables
    • Software
    • Services
  • By Application
    • Drug discovery
    • Cancer Research
    • Neuroscience
    • Stem Cell Research and Regenerative Medicine
    • Personalized Medicine
    • Others
  • By Technology
    • Microscopy
    • Flow Cytometry
    • Single-cell Genomics
    • Mass Spectrometry
    • Next Generation Sequencing
    • Others
  • By End User
    • Biotechnology & Pharmaceutical Companies
    • Hospitals & Diagnostic Laboratories
    • Contract Research Organizations
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Thermo Fisher Scientific
    • Danaher
    • PerkinElmer
    • BD
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Illumina
    • Luminex
    • Merck KGaA
    • GE Healthcare
    • Bruker
    • Nanostring Technologies
    • 10x Genomics
    • Fluidigm
    • Celsee
    • Berkeley Lights
    • Miltenyi Biotec
    • Bionano Genomics
    • Bio-Techne
    • Sphere Fluidics

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global High End Cellomics Market, By Product Type
    • Global High End Cellomics Market, By Application
    • Global High End Cellomics Market, By Technology
    • Global High End Cellomics Market, By End User
    • Global High End Cellomics Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand for personalized medicine
    • Restraints
  • High costs associated with the procurement and maintenance of advanced cell analysis instruments
    • Opportunities
  • Emergence of new cellular analysis techniques such as single-cell sequencing and spatial transcriptomics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global High End Cellomics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global High End Cellomics Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Reagents & Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global High End Cellomics Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Drug discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Cancer Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Neuroscience
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Stem Cell Research and Regenerative Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global High End Cellomics Market, By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Microscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Single-cell Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Next Generation Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global High End Cellomics Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biotechnology & Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Hospitals & Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global High End Cellomics Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • China
      • Japan
      • India
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • PerkinElmer
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Illumina
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Luminex
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bruker
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nanostring Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • 10x Genomics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Fluidigm
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Celsee
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Berkeley Lights
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Miltenyi Biotec
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bionano Genomics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Techne
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sphere Fluidics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us